Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of the 9-valent HPV vaccine in men.
Castellsagué X, Giuliano AR, Goldstone S, Guevara A, Mogensen O, Palefsky JM, Group T, Shields C, Liu K, Maansson R, Luxembourg A, Kaplan SS. Castellsagué X, et al. Among authors: guevara a. Vaccine. 2015 Nov 27;33(48):6892-901. doi: 10.1016/j.vaccine.2015.06.088. Epub 2015 Jul 2. Vaccine. 2015. PMID: 26144901
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.
Ruiz-Sternberg ÁM, Moreira ED Jr, Restrepo JA, Lazcano-Ponce E, Cabello R, Silva A, Andrade R, Revollo F, Uscanga S, Victoria A, Guevara AM, Luna J, Plata M, Dominguez CN, Fedrizzi E, Suarez E, Reina JC, Ellison MC, Moeller E, Ritter M, Shields C, Cashat M, Perez G, Luxembourg A. Ruiz-Sternberg ÁM, et al. Among authors: guevara am. Papillomavirus Res. 2018 Jun;5:63-74. doi: 10.1016/j.pvr.2017.12.004. Epub 2017 Dec 19. Papillomavirus Res. 2018. PMID: 29269325 Free PMC article. Clinical Trial.
Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies.
Giuliano AR, Palefsky JM, Goldstone SE, Bornstein J, De Coster I, Guevara AM, Mogensen O, Schilling A, Van Damme P, Vandermeulen C, Ellison MC; Thomas Group; Kaplan S, Lin J, Bonawitz R, Luxembourg A. Giuliano AR, et al. Among authors: guevara am. Hum Vaccin Immunother. 2025 Dec;21(1):2425146. doi: 10.1080/21645515.2024.2425146. Epub 2025 Jan 22. Hum Vaccin Immunother. 2025. PMID: 39840832 Free article. Clinical Trial.
An Unusual Presentation of Cutaneous Bullous Lupus.
Buchner SH, Malta K, Wang S, Guevara A, Glickman C, Hookim K, Traisak P, Karpoff M, Feinstein D, Eid H. Buchner SH, et al. Among authors: guevara a. Cureus. 2024 Nov 21;16(11):e74140. doi: 10.7759/cureus.74140. eCollection 2024 Nov. Cureus. 2024. PMID: 39712850 Free PMC article.
Risk Factors in Optimal Management of Hypertension in Elderly Patients Following 2017 American College of Cardiology-American Heart Association Guidelines.
Walder Z, Prasad S, Guevara A, Souedy AA, Martirosyan D, Moshman R, Porter A, Morris N, Khatiwala P, Thampi S, Hunter K, Roy S. Walder Z, et al. Among authors: guevara a. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241306897. doi: 10.1177/21501319241306897. J Prim Care Community Health. 2024. PMID: 39676249 Free PMC article.
219 results